AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 DEC 2 - (NewsRx.com & NewsRx.net) -- OmniCorder Technologies, Inc., (OMCT) announced the delivery of a new cancer therapy monitoring configuration of its BioScanIR System to The Cleveland Clinic.
The system will be used to detect the effects of cancer treatments in patients undergoing neoadjuvant breast cancer therapy as part of a collaboration between OmniCorder Technologies and the Case Comprehensive Cancer Center, which includes The Cleveland Clinic Taussig Cancer Center and Case Western Reserve University School of Medicine.
The system, which has been specifically configured for this application, will be used as part of an international study to monitor breast cancer patients undergoing this new treatment protocol. This approach to breast cancer therapy which involves administering drug therapy prior to surgery seeks to reduce tumor size and ...